Nervgen Pharma NGEN
NASDAQ NGEN
$1.78 +0.02 (+1.14%)
At close: Oct 2, 2026 · 4:00 PM EDT

Nervgen Pharma (NGEN) Selling, General & Administrative (2025 - 2026)

Updated

Nervgen Pharma's Selling, General & Administrative was $3.11 million in the quarter ended Jun 30, 2026, up 14.8% from $2.71 million a year earlier and up 60.0% from the prior quarter.

Analysis

Nervgen Pharma (NGEN) Selling, General & Administrative (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Nervgen Pharma's Selling, General & Administrative was $9.78 million through Jun 30, 2026; for the year ended Dec 31, 2025, it came in at $8 million, up 16.9% from the prior year.

  • In earlier years, Selling, General & Administrative was $6.84 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Nervgen Pharma 141.78 Mn 141.78 Mn - 3.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.11 Mn
Mar 31, 2026 1.95 Mn
Jun 30, 2025 2.71 Mn
Mar 31, 2025 2.01 Mn
API Access

Nervgen Pharma Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NGEN&period=max&api_key=YOUR_API_KEY